CD34 stem cell therapy (LA Childrens Hospital)

N/A

Report date: 2023/12/04 20:05:36

Base Information

Drug NameCD34 stem cell therapy (LA Childrens Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionHematopoietic progenitor cell antigen CD34 agonists
TargetsHematopoietic progenitor cell antigen CD34
Therapy Area/IndicationsHeart FailureHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySlovenia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesChildren'S Hospital Of Los Angeles
China Registration ClassN/A

Develop Information

Active CompaniesLjubljana University Medical Centre
Inactive CompaniesChildren'S Hospital Of Los Angeles
Active IndicationsHeart Failure
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A